BRIEF-Trillium Therapeutics doses first patient with TTI-621 in phase 1 solid tumor trial
* Trillium Therapeutics doses first patient with TTI-621 in phase 1 solid tumor trial Source text for Eikon: Further company coverage: [Source]
Publication Date:Origin: reuters.com
Category: governmentFilingsNews
Topics: tumor, solid, TTI-621, patient, first, doses, Therapeutics, coverage, company, Further, Eikon, trial Source, in phase, Trillium, trial, phase, BRIEF-Trillium
Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/eoTKa527KT8/idUSASB0AXKK